Skip to main content

Table 3 Contents and results of radiotherapy (with or without chemotherapy) for postoperative recurrent esophageal cancer. in previous studies. The numbers in parenthesis are a numbers of patients.

From: Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-Fluorouracil for postoperative locoregional recurrent esophageal cancer

author

year

No.

regimen

response rate

median survival time

1-year survuval rate

JL Raoul [13]

1995

24

radiotherapy + chemotherapy

65%

-

47.1%

H Yamanaka [25]

1998

17

radiotherapy + CDGP§ + 5-FU#

76.50%

-

-

K Nemoto [15]

2001

33

radiotherapy alone(21) or radiotherapy + CDDP* + 5-FU (12)

-

7 months

33%

Y Nishimura [12]

2003

13

radiotherapy + CDDP + 5-FU

72%

9.5 months

28%

H Shimada [14]

2003

76

chemoradiotheray(47), chemotherapy alone(17), radiotherapy alone(12)

34%

8 months

31%

K Nemoto [16]

2003

7

radiotherapy + CDGP + 5-FU

100%

-

69%

  1. * CDDP: cisplatin, § CDGP: nedaplatin, # 5-FU: 5-fluorouracil